Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is partly caused by specific genes, but most genetic factors are still unknown.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

DHEA inhibits growth in both mouse and human melanoma cells but works differently in each.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Different genes are linked to various types of hair loss.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Estrogens and androgens are crucial for male fertility.

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CAG repeat numbers in the AR gene likely don't affect male pattern baldness in Korean men.

Male pattern baldness is a genetic condition causing hair loss, with limited but improving treatment options.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Early diagnosis and treatment are crucial for complex medical conditions.

The AR gene is linked to male-pattern baldness, TNFSF4 to heart disease, SLC19A3 to BBGD, MCT8 to a syndrome, and segmental duplications to genetic variation.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

Androgenetic alopecia is linked to family history and androgen effects.

Different substances affect hair and skin cell growth in various ways.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Androgen receptor expression is similar in affected and unaffected scalp areas in androgenetic alopecia.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.